VITROS CHEMISTRY PRODUCTS IGA REAGENT 6801732

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2018-08-30 for VITROS CHEMISTRY PRODUCTS IGA REAGENT 6801732 manufactured by Ortho-clinical Diagnostics.

Event Text Entries

[120128076] The investigation has determined that a non-reproducible, lower than expected vitros iga result was obtained from a single patient sample tested on a vitros 4600 system. The likely assignable cause of the event could not be determined. A review of the tca files generated from the vas track system did not indicate any errors occurred when the sample was initially processed from the track system. It is unknown at what relative centrifugal force or the centrifugation time at which the affected sample was processed, therefore, it is unknown if the customer is following the sample collection device manufacture? S recommendation for sample centrifugation. It is possible that cellular debris, due to poor sample preparation, was present in the affected samples, although this could not be confirmed. A vitros igm within-run precision test, used to assess the performance of the vitros 4600 chemistry system, was not performed; therefore, an instrument related issue cannot be ruled out as contributing to the event. A review of historical vitros iga quality control results were acceptable, indicating a reagent related issue did not likely contribute to the event. In addition, ongoing tracking and trending of complaints has not identified any signals that would suggest there is a systemic issue with vitros iga reagent lot 1503-10-6137.
Patient Sequence No: 1, Text Type: N, H10


[120128077] A customer obtained a non-reproducible, lower than expected vitros iga result from a single patient sample tested on a vitros 4600 system. Patient sample result of 1. 31 g/l vs. The expected results of 2. 94 and 2. 98 g/l. A biased result of the direction and magnitude observed may lead to inappropriate medical action if not detected. The lower than expected vitros iga result of 1. 31 g/l was reported outside of the laboratory, however, a corrected report was issued and there was no allegation of patient harm as a result of this event. This report corresponds to ortho clinical diagnostics inc. (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1319808-2018-00023
MDR Report Key7833575
Date Received2018-08-30
Date of Report2018-08-30
Date of Event2018-07-26
Date Mfgr Received2018-08-03
Device Manufacturer Date2017-08-23
Date Added to Maude2018-08-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JAMES A STEVENS
Manufacturer Street100 INDIGO CREEK DRIVE
Manufacturer CityROCHESTER NY 14626
Manufacturer CountryUS
Manufacturer Postal14626
Manufacturer Phone5854533000
Manufacturer G1ORTHO-CLINICAL DIAGNOSTICS
Manufacturer Street1000 LEE ROAD
Manufacturer CityROCHESTER NY 14606
Manufacturer CountryUS
Manufacturer Postal Code14606
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameVITROS CHEMISTRY PRODUCTS IGA REAGENT
Generic NameINVITRO DIAGNOSTIC
Product CodeCFN
Date Received2018-08-30
Catalog Number6801732
Lot Number1503-10-6137
Device Expiration Date2018-10-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerORTHO-CLINICAL DIAGNOSTICS
Manufacturer Address100 INDIGO CREEK DRIVE ROCHESTER NY 14626 US 14626


Patients

Patient NumberTreatmentOutcomeDate
10 2018-08-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.